Skip to content

News

In Loving Memory of Elle Simone Scott

In Loving Memory of Elle Simone Scott

We mourn the loss of Elle Simone Scott—a force of creativity, generosity, and purpose whose influence reached far beyond the kitchen. As tributes continue to pour in from across the culinary world, creative industries, and advocacy spaces, it is clear just how deeply Elle touched lives through her work, her mentorship, and her commitment to equity … Continued

OCRA VP of Policy Featured in Citybiz on Launch of New Center for Public Policy

OCRA VP of Policy Featured in Citybiz on Launch of New Center for Public Policy

In a new piece published by citybiz, OCRA’s Vice President, Policy, Chad Ramsey, discusses the launch of OCRA’s Center for Public Policy, highlighting its role in expanding critical advocacy work and bringing more agency to the gynecologic cancer community. Ramsey explains how patient, survivor, and caregiver experiences have helped shape OCRA’s advocacy priorities over the past … Continued

The Overview: December 2025

The Overview: December 2025

Friends: This has been a pivotal year for Ovarian Cancer Research Alliance (OCRA), defined by powerful forward momentum—from launching the Global Ovarian Cancer Research Consortium to preparing the Community Accelerated Research Exchange for its debut, expanding essential support and education programs, and establishing our new Center for Public Policy. These developments, along with the progress highlighted below, signal a turning … Continued

The Overview: November 2025

The Overview: November 2025

Friends, As we approach the end of the year, one thing stands out above all else: this is a moment of unprecedented opportunity to accelerate progress against ovarian and all gynecologic cancers. And thanks to you, OCRA is rising to meet that moment — driving innovation, expanding support, and providing the community that so many … Continued

OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025

OCRA Board Member Laura Shawver, PhD, Named to Fierce 50 of 2025

Ovarian Cancer Research Alliance (OCRA) congratulates board member Laura Shawver, PhD, on her selection to the Fierce 50 of 2025, a leading industry award from Fierce Life Sciences recognizing individuals and organizations advancing what’s possible in health, science and patient care. Dr. Shawver was selected for her long-standing leadership in oncology research and drug development, … Continued

Donate to Drive Progress Against Ovarian and Gynecologic Cancer This Giving Season

Donate to Drive Progress Against Ovarian and Gynecologic Cancer This Giving Season

YOU Can Help Shape the Future of Ovarian and Gynecologic Cancer Care Together we are driving research breakthroughs and helping patients and families facing gynecologic cancer to access critical support. Your generous donation brings us one step closer to reaching our important $2 million year-end fundraising goal, and an even more impactful 2026. Ovarian Cancer … Continued

Ovarian Cancer Research Alliance Launches Center for Public Policy to Strengthen National Voice for Ovarian and Gynecologic Cancers

Ovarian Cancer Research Alliance Launches Center for Public Policy to Strengthen National Voice for Ovarian and Gynecologic Cancers

New policy hub builds on record of helping to secure billions in federal funding and training thousands of advocates, with expanded priorities and an interactive policy map New York, NY – [November 20, 2025] — Ovarian Cancer Research Alliance (OCRA) today announced the launch of its Center for Public Policy, a dedicated hub that reflects expanded policy … Continued

OCRA Invests More than $10.8 Million Toward Research, Part of $14.5 Million Commitment in 2025

OCRA Invests More than $10.8 Million Toward Research, Part of $14.5 Million Commitment in 2025

In 2025, Ovarian Cancer Research Alliance (OCRA) invested more than $10.8 million toward scientific research—part of our $14.5 million commitment to strengthen the community through research, patient support, education and advocacy. This year’s investment represents OCRA’s broadest scope to date, encompassing not only our renowned grant programs but also global collaborations leveraging artificial intelligence (AI) … Continued

The Overview: October 2025

The Overview: October 2025

KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued

KVIA-TV ABC-7 Features OCRA-Funded Research Developing Nanotechnology for Ovarian Cancer Detection

KVIA-TV ABC-7 Features OCRA-Funded Research Developing Nanotechnology for Ovarian Cancer Detection

KVIA-TV ABC-7 News El Paso recently spotlighted the groundbreaking work of OCRA-funded researcher Daniel Heller, PhD of Memorial Sloan Kettering Cancer Center, whose research lab is working to develop a liquid biopsy that uses nanotechnology and artificial intelligence (AI) to detect ovarian cancer earlier. We’re developing a liquid biopsy that uses nano sensors and AI … Continued

Free Educational Videos on Ovarian and Gynecologic Cancer Now Available

Free Educational Videos on Ovarian and Gynecologic Cancer Now Available

Videos from the Ovarian Cancer Research Alliance (OCRA) 2025 International Gynecologic Cancer Conference are now available to watch online — offering free educational sessions on ovarian and gynecologic cancer research, treatment, and patient care. For the first time, OCRA is releasing the full suite of videos shortly after the event — removing barriers to access so that anyone can learn directly from top experts. … Continued

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.